Ependymomas in Children Express the Multidrug Resistance Gene: Immunohistochemical and Molecular Biologic Study

References

• Juliano R L, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152–62
   PubMed Web of Science ®Google Scholar
• Gros P, Ben Neriah Y, Croop J M, Housman D E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 1986; 323: 728–31
   PubMed Web of Science ®Google Scholar
• Chan H SL, Haddad G, Thorner P S. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 1991; 325: 1608–14
   PubMed Web of Science ®Google Scholar
• Chan H SL, Thorner P S, Haddad G, Ling V. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990; 8: 689–704
   PubMed Web of Science ®Google Scholar
• Beardsley T. Trends in cancer epidemiology. A war not won. Sci Am 1994; 270: 130–8
   PubMedGoogle Scholar
• De la Torre L, Ridaura Sanz C, Reyes-Mujica M, Rueda Franco F. Central nervous system tumors in Mexican children. Childs Nerv Syst 1993; 9: 260–5
   PubMed Web of Science ®Google Scholar
• Robison L L, Mertens A, Neglia J P. Epidemiology and etiology of childhood cancer. Clinical Pediatric Oncology, 4th ed, D J Fernbach, T J Vietti. C. V. Mosby, St Louis 1991; 11–28
   Google Scholar
• Black P M. Brain tumors (part 1). N Engl J Med 1991; 324: 1471–6
   PubMed Web of Science ®Google Scholar
• Black P M. Brain tumors (part 2). N Engl J Med 1991; 324: 1555–64
   PubMed Web of Science ®Google Scholar
• West C R, Bruce D A, Duffner P K. Ependymomas. Factors in clinical and diagnostic staging. Cancer 1985; 56: 1812–16
   PubMed Web of Science ®Google Scholar
• Schiffer D, Chiö A, Giordana M T, et al. Histologie prognostic factors in ependymomas. Childs Nerv Syst 1991; 7: 177–82
   PubMed Web of Science ®Google Scholar
• Healy E A, Barnes P D, Kupsky W J, et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 1991; 28: 606–72
   PubMed Web of Science ®Google Scholar
• Goldwein J W, Glauser T A, Packer R J, et al. Recurrent intracranial ependymomas in children. Survival, patterns of failure and prognostic factors. Cancer 1990; 66: 557–63
   PubMed Web of Science ®Google Scholar
• Mork S J, Loken A C. Ependymoma. A follow-up study of 101 cases. Cancer 1977; 40: 907–15
   PubMed Web of Science ®Google Scholar
• Tomita T, McLone D G, Das L, Brand W N. Benign ependymomas of the posterior fossa in childhood. Pediatr Neurosci 1988; 14: 277–85
   PubMedGoogle Scholar
• Freidman H S, Oakes W J. The chemotherapy of posterior fossa tumors in childhood. J Neurooncol 1987; 5: 217–29
   PubMed Web of Science ®Google Scholar
• Dietel M. Second International Symposium on Cytostatic Drug Resistance. Cancer Res 1993; 53: 2683–8
   PubMed Web of Science ®Google Scholar
• Philips P C. Antineoplastic drug resistance in brain tumors. Brain tumors in children. Neurol Clin 1991; 9: 383–404
   PubMed Web of Science ®Google Scholar
• Raderer M, Scheithauer W. Clinical trials of agents that reverse multidrug resistance. Cancer 1993; 72: 3553–63
   PubMed Web of Science ®Google Scholar
• Pearson J W, Fogler W E, Volker K, et al. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody. J Natl Cancer Inst 1991; 83: 1386–91
   PubMed Web of Science ®Google Scholar
• Beck W T. Do anti-P-glycoprotein antibodies have a future in the circumvention of multidrug resistance?. J Natl Cancer Inst 1991; 83: 1364–6
   PubMedGoogle Scholar
• Mechetner E B. Roninson IB. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci USA 1992; 89: 5824–8
   PubMed Web of Science ®Google Scholar
• Kartner N, Evernden-Porelle D, Bradley G, Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1985; 316: 820–3
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien J P, Boccia J, Casals D, Bertino J R, Melamed M R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990; 38: 1277–87
   PubMed Web of Science ®Google Scholar
• Chirgwin J, Przybyla A, MacDonald R, Rutter W J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–9
   PubMed Web of Science ®Google Scholar
• Noonan K E, Beck C, Holzmayer T A, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 7160–4
   PubMed Web of Science ®Google Scholar
• Cohen M E, Duffner P K. Ependymomas. Brain Tumors of Childhood: Principles of Diagnosis and Treatment, M E Cohen. Raven Press, New York 1994; 219–39
   Google Scholar
• Ross G W, Rubinstein L J. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 1989; 70: 31–6
   PubMed Web of Science ®Google Scholar
• Reyes-Mugica M, Chou P M, Myint M M, Ridaura-Sanz C, Gonzalez-Crussi F, Tomita T. Ependymomas in children: Histologie and DNA-flow cytometric study. Pediatr Pathol 1994; 14: 453–66
   PubMed Web of Science ®Google Scholar
• Allen J C. What we learn from infants with brain tumors. N Engl J Med 1993; 328: 1780–2
   PubMed Web of Science ®Google Scholar
• Duffner P K, Horowitz M E, Krischer J P, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993; 328: 1725–31
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien J P, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695–8
   PubMed Web of Science ®Google Scholar
• Hegmann E J, Bauer H C, Kerbel R S. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res 1992; 52: 6969–75
   PubMed Web of Science ®Google Scholar
• Biedler J L. Genetic aspects of multidrug resistance. Cancer 1992; 70: 1799–1809
   PubMed Web of Science ®Google Scholar
• Henson J W, Cordon-Cardo C, Posner J B. P-glycoprotein expression in brain tumors. J Neurooncol 1992; 14: 37–43
   PubMed Web of Science ®Google Scholar
• Schinkel A H, Smit J JM, ran Tellingen O, et al. Disruption of the mouse MDR1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491–502
   PubMed Web of Science ®Google Scholar
• Geddes J F, Vowles G H, Ashmore S M, et al. Detection of multidrug resistance gene product (P-glycoprotein) expression in ependymomas. Neuropathol Appl Neurobiol 1994; 20: 118–21
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Tani E, Kaba K, et al. Amplification and expression of a multidrug resistance gene in human glioma cell lines. J Neurosurg 1990; 72: 96–101
   PubMed Web of Science ®Google Scholar
• Becker I, Becker K P, Meyermann R, Hollt V. The multidrug-resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol 1991; 82: 516–9
   PubMed Web of Science ®Google Scholar
• Tishler M D, Weinberg K I, Sender L S, Nolta A J, Raffel C. Multidrug resistance gene expression in pediatric primitive neuroectodermal tumors of the central nervous system. J Neurosurg 1992; 76: 507–12
   PubMed Web of Science ®Google Scholar
• Nabors M W, Griffin C A, Zehnbauer B A, et al. Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 1991; 75: 941–6
   PubMed Web of Science ®Google Scholar
• van Kalken C K, Giaccone G, van der Valk P, et al. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol 1992; 141: 1063–72
   PubMed Web of Science ®Google Scholar
• Gottesman M M, Willingham M C, Thiebaut F, Pastan I. Expression of the MDR1 gene in normal human tissues. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, I B Roninson. Plenum Publishing, New York 1991; 279–88
   Google Scholar
• Gottesman M M. How Cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1993; 53: 747–54
   PubMed Web of Science ®Google Scholar
• Kaye S B. P-glycoprotein (Pgp) and drug resistance—time for reappraisal?. Br J Cancer 1993; 67: 641–3
   PubMed Web of Science ®Google Scholar
• Goldstein L J, Galski H, Fojo A, et al. Expression of a multidrug resistant gene in human cancers. J Natl Cancer Inst 1989; 81: 116–24
   PubMed Web of Science ®Google Scholar
• Thorgeirsson S S, Huber B E, Sorrell S, Fojo A, Pastan I, Gottesman M M. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 1987; 236: 1120–2
   PubMed Web of Science ®Google Scholar
• Moulder J E, Hopwood L E, Volk D M, Davies B M. Radiation induction of drug resistance in RIF-1: Correlation of tumor and cell culture results. Int J Radiat Oncol Biol Phys 1991; 20: 213–6
   PubMed Web of Science ®Google Scholar
• Ozols R F, Masuda H, Hamilton T C. Mechanisms of cross-resistance between radiation and antineo-plastic drugs. Monogr Natl Cancer Inst 1988; 6: 159–65
   Google Scholar
• Mousseau M, Chauvin C, Nissou M P, et al. A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumors. Eur J Cancer 1993; 29A: 753–9
   PubMed Web of Science ®Google Scholar
• Bradley G, Sharma R, Rajalakshmi S, Ling V. P-glycoprotein expression during tumor progression in the rat liver. Cancer Res 1992; 52: 5154–61
   PubMed Web of Science ®Google Scholar
• Weinstein R S, Jakate S M, Dominguez J M, et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991; 51: 2720–6
   PubMed Web of Science ®Google Scholar